Salvatore Piscuoglio

机构：Humanitas University, University of Basel, University Hospital of Basel, University Hospital Zurich, IRCCS Humanitas Research Hospital · ORCID：0000-0003-2686-2939

发表论文 581 篇 · 总被引 13090 次 · h-index 59

代表论文

• The Novel HSF1 Inhibitor NXP800 Exhibits Robust Antitumor Activity in Hepatocellular Carcinoma (2026 · International Journal of Molecular Sciences · 被引 1)
• Safety of Multi-Omics–Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis (2026 · JCO Precision Oncology · 被引 1)
• Combined Casein Kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer (2026 · Zenodo (CERN European Organization for Nuclear Research))
• Supplemental Material for: ENDOTHELIAL CELLS CONTRIBUTE TO THE IMMUNE-VASCULAR MILIEU CHARACTERIZING VETC+ HCC (2026 · Figshare)
• Combined Casein Kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer (2026 · Zenodo (CERN European Organization for Nuclear Research))
• Supplemental Material for: ENDOTHELIAL CELLS CONTRIBUTE TO THE IMMUNE-VASCULAR MILIEU CHARACTERIZING VETC+ HCC (2026 · Figshare)